BioTech/Drugs - Durham, NC, US
We're leveraging our patented technology to produce nutritionally equivalent breastmilk from cultured human mammary cells. With Biomilq, families can achieve the recommended six months of exclusive breastfeeding while alleviating the climate impacts of bovine-based infant formula.
Gmail
Google Tag Manager
Facebook Login (Connect)
Mobile Friendly